Wednesday, July 8, 2026

pharma · Chronic Lymphocytic Leukaemia (CLL)

Servier Australia

Servier Australia clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Melbourne, AU HQ
1954 Founded
11 Employees
TGA registrant Type
Company details
Intelligence · Clinical Programs

Servier Australia projects

1 ClinicalTrials.gov programs sponsored by Servier Australia.

Servier Australia has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. S 55746

    Servier Laboratories (Aust.) Pty.

    Chronic Lymphocytic Leukaemia (CLL)

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Servier Australia have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.